Second Sight Medical Products, Inc (EYES)

Etorro trading 970x250

About Second Sight Medical Products, Inc

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California. Address: 13170 Telfair Avenue, Sylmar, CA, United States, 91342

Second Sight Medical Products, Inc News and around…

Latest news about Second Sight Medical Products, Inc (EYES) common stock and company :

Insiders Buy Around $2M Of 2 Penny Stocks
26 May, 2022 FinancialContent

US stock futures traded higher on Thursday, with the Dow futures adding more than 200 points this morning. Investors, meanwhile, ...

Top Buys by Directors: Williams's $1.4M Bet on EYES
23 May, 2022 FinancialContent

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..

Interesting EYES Call Options For November 18th
28 Apr, 2022 FinancialContent

Investors in Second Sight Medical Products Inc (EYES) saw new options become available this week, for the November 18th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 204 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®
14 Apr, 2022 FinancialContent

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. (“NPM”), will air on The RedChip Money Report® on Bloomberg US on April 16 at 7 p.m. Eastern Time (ET). Bloomberg US is available in an estimated 73 million homes across the United States.

LBank Exchange Listed EYES Protocol (EYES) on February 25, 2022
28 Feb, 2022 FinancialContent
EYES Stock Investigation: Halper Sadeh LLP Is Investigating Whether the Merger of Second Sight Medical Products, Inc. Is Fair to Shareholders
09 Feb, 2022 FinancialContent

Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Second Sight Medical Products, Inc. (NASDAQ: EYES) and Nano Precision Medical, Inc. is fair to Second Sight shareholders.

51 Biggest Movers From Yesterday
09 Feb, 2022 FinancialContent

Gainers Society Pass Incorporated(NASDAQ: SOPA) shares climbed 42.7% to close at $4.68 on Tuesday after dropping ...

35 Stocks Moving In Tuesday's Mid-Day Session
08 Feb, 2022 FinancialContent

Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, ...

EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.
08 Feb, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips EYES stock is up 15% today on news that Second Sight Medical is making a strategic acquisition. Here's what to know. The post EYES Stock Pops on Biotech Merger Plans. 5 Things to Know. appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
08 Feb, 2022 FinancialContent

Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
08 Feb, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We've got another busy day ahead of us so let's get right into it with the biggest pre-market stock movers for Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical
08 Feb, 2022 FinancialContent

Second Sight Medical Products Inc(NASDAQ: EYES) will acquire privately-heldNano Precision Medical Incin an all-stock ...

21 Stocks Moving in Tuesday's Pre-Market Session
08 Feb, 2022 FinancialContent

Gainers American Rebel Holdings, Inc.(NASDAQ: AREB) rose 142% to $5.35 in pre-market trading following uplisting ...

Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company
07 Feb, 2022 FinancialContent

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”) and Nano Precision Medical, Inc. (“NPM”), today announced that they have entered into a definitive agreement under which privately held NPM will merge with a wholly owned subsidiary of Second Sight in an all-stock transaction. NPM will be the surviving company and owned by Second Sight. The resulting company will focus on development of innovative drug and device medical implants that treat chronic diseases with high unmet medical need.

Can NeuroOne Medical Technologies (NASDAQ:NMTC) Drive the Shift from Science Fiction to Science Fact
07 Feb, 2022 FinancialContent
Leading K-Beauty Brand LaStella Launches Premier Ampoule Serum to Fight Aging and Dark Circles Under Eyes
30 Dec, 2021 FinancialContent
Pristene® Premium Ocular Health Supplements is Unlocking Powerful Nutrition for Optimal Eye Health
29 Dec, 2021 FinancialContent
ATOPALM Launches Moisturizing Eye Repair Serum to Fight Dryness and Premature Aging Around Eyes in Winter Months
02 Dec, 2021 FinancialContent
61 Biggest Movers From Yesterday
18 Nov, 2021 FinancialContent

Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
17 Nov, 2021 FinancialContent

Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) shares moved upwards by 25.83% to $17.68 during Wednesday's regular session. The ...

42 Stocks Moving In Wednesday's Mid-Day Session
17 Nov, 2021 FinancialContent

Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
17 Nov, 2021 FinancialContent

Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
17 Nov, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

25 Stocks Moving in Wednesday's Pre-Market Session
17 Nov, 2021 FinancialContent

Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & ...

80 Biggest Movers From Yesterday
17 Nov, 2021 FinancialContent

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a ...

Interesting EYES Put And Call Options For January 2024
08 Nov, 2021 FinancialContent

Investors in Second Sight Medical Products Inc (EYES) saw new options begin trading this week, for the January 2024 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 802 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

12 Health Care Stocks Moving In Thursday's After-Market Session
21 Oct, 2021 FinancialContent

Gainers T2 Biosystems (NASDAQ:TTOO) shares increased by 23.47% to $1.02 during Thursday's after-market session. T2 Biosystems's ...

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
11 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study
11 Aug, 2021 FinancialContent

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announces that the Company received a grant supplement from the National Institutes of Health (NIH) to fund a qualitative study to gather critical insights into how profoundly blind people weigh the risks and benefits of visual neuroprostheses. The study will help the Company better understand acceptable risks, necessary benefits, and appropriate risk/benefit balance for visual cortical prostheses, from the perspective of the target population. The entirety of the $155,964 grant supplement will be provided to UCLA as a subcontractor to conduct the study. The grant supplement is related to the $6.4 million NIH grant for the Early Feasibility Clinical Trial of a Visual Cortical Prosthesis, grant UH3NS103442. Second Sight reported promising two-year data from the Orion trial on May 12, 2021.

12 Health Care Stocks Moving In Friday's After-Market Session
23 Jul, 2021 FinancialContent

Gainers NanoVibronix (NASDAQ:NAOV) shares rose 21.45% to $3.17 during Friday's after-market session. This security traded at a ...

Second Sight Medical Products, Inc (EYES) is a NASDAQ Common Stock listed in , ,

970x250